speb/financial-data huggingface dataset:
NTES cash_flow (annual, 2024-12-31) — Changes In Cash: 30257513000.00
NTES balance_sheet (annual, 2024-12-31) — Common Stock: 2631000.00
NTES balance_sheet (quarterly, 2024-12-31) — Common Stock: 2631000.00
NTES cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -11165338000.00
NTES balance_sheet (annual, 2024-12-31) — Common Stock Equity: 138685606000.00
NTES cash_flow (annual, 2024-12-31) — Common Stock Payments: -8830115000.00
NTES cash_flow (quarterly, 2024-12-31) — Common Stock Payments: -1595093000.00
NTES balance_sheet (annual, 2024-12-31) — Construction In Progress: 1696018000.00
NTES balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 1696018000.00
NTES income_statement (annual, 2024-12-31) — Cost Of Revenue: 39488152000.00
NTES balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 8871814000.00
NTES balance_sheet (annual, 2024-12-31) — Current Assets: 153324656000.00
NTES balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 171609000.00
NTES balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 171609000.00
NTES balance_sheet (annual, 2024-12-31) — Current Debt: 11805051000.00
NTES balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 11976660000.00
NTES balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 19644002000.00
NTES balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 19644002000.00
NTES balance_sheet (annual, 2024-12-31) — Current Liabilities: 49667657000.00
NTES cash_flow (annual, 2024-12-31) — Deferred Income Tax: 320726000.00
NTES cash_flow (annual, 2024-12-31) — Deferred Tax: 320726000.00
NTES cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 2417894000.00
NTES cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 2417894000.00
NTES income_statement (annual, 2024-12-31) — Diluted Average Shares: 646120400.00
NTES income_statement (annual, 2024-12-31) — Diluted EPS: 45.95
NTES income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 29697609000.00
NTES income_statement (annual, 2024-12-31) — EBIT: 29583990000.00
NTES income_statement (annual, 2024-12-31) — EBITDA: 32001884000.00
NTES cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: 155568000.00
NTES cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 10752000.00
NTES cash_flow (annual, 2024-12-31) — End Cash Position: 54474923000.00
NTES cash_flow (annual, 2024-12-31) — Financing Cash Flow: -27335702000.00
NTES cash_flow (annual, 2024-12-31) — Free Cash Flow: 37470425000.00
NTES cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -272415000.00
NTES cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: -4758000.00
NTES income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 610716000.00
NTES balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 2961679000.00
NTES balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 2961679000.00
NTES income_statement (annual, 2024-12-31) — General And Administrative Expense: 4550625000.00
NTES balance_sheet (annual, 2024-12-31) — Goodwill: 1855293000.00
NTES balance_sheet (quarterly, 2024-12-31) — Goodwill: 1855293000.00
NTES balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 7440689000.00
NTES balance_sheet (annual, 2024-12-31) — Gross PPE: 16410784000.00
NTES income_statement (annual, 2024-12-31) — Gross Profit: 65807084000.00
NTES cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 5189585000.00
NTES balance_sheet (annual, 2024-12-31) — Income Tax Payable: 1740126000.00
NTES balance_sheet (quarterly, 2024-12-31) — Income Tax Payable: 1740126000.00
NTES income_statement (annual, 2024-12-31) — Interest Income: 4920915000.00
NTES income_statement (annual, 2024-12-31) — Interest Income Non Operating: 4920915000.00
NTES cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 489622000.00
NTES balance_sheet (annual, 2024-12-31) — Inventory: 571548000.00
NTES balance_sheet (annual, 2024-12-31) — Invested Capital: 150918654000.00
NTES cash_flow (annual, 2024-12-31) — Investing Cash Flow: 17916402000.00
NTES balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 16505295000.00
NTES balance_sheet (annual, 2024-12-31) — Investments And Advances: 23231356000.00
NTES cash_flow (annual, 2024-12-31) — Issuance Of Debt: 13920080000.00
NTES balance_sheet (annual, 2024-12-31) — Leases: 197230000.00
NTES balance_sheet (quarterly, 2024-12-31) — Leases: 197230000.00
NTES balance_sheet (annual, 2024-12-31) — Line Of Credit: 11805051000.00
NTES balance_sheet (annual, 2024-12-31) — Loans Receivable: 13196000.00
NTES balance_sheet (quarterly, 2024-12-31) — Loans Receivable: 13196000.00
NTES balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 412600000.00
NTES balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 412600000.00
NTES balance_sheet (annual, 2024-12-31) — Long Term Debt: 427997000.00
NTES balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 427997000.00
NTES balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 840597000.00
NTES balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 840597000.00
NTES cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 13920080000.00
NTES cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -14739347000.00
NTES balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 6406167000.00
NTES balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 6406167000.00
NTES balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 7087792000.00
NTES balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 7087792000.00
NTES balance_sheet (annual, 2024-12-31) — Minority Interest: 3808532000.00
NTES income_statement (annual, 2024-12-31) — Minority Interests: -558738000.00
NTES cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 2309188000.00
NTES cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -8830115000.00
NTES cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -719162000.00
NTES income_statement (annual, 2024-12-31) — Net Income: 29697609000.00
NTES income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 29697609000.00
NTES income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 30256347000.00
NTES income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: 0.00
NTES income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 29697609000.00
NTES income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 29697609000.00
NTES cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 30256347000.00
NTES income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 30256347000.00
NTES cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -930988000.00
NTES income_statement (annual, 2024-12-31) — Net Interest Income: 4920915000.00
NTES cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 18613957000.00
NTES cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -7476255000.00
NTES cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -819267000.00
NTES income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 4920915000.00
NTES cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 136006000.00
NTES cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -814888000.00
NTES balance_sheet (annual, 2024-12-31) — Net PPE: 9061172000.00
NTES cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -1260867000.00
NTES cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: -6656988000.00
NTES balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 131244917000.00
NTES balance_sheet (annual, 2024-12-31) — Non Current Accounts Receivable: 1243512000.00
NTES balance_sheet (quarterly, 2024-12-31) — Non Current Accounts Receivable: 1243512000.00
NTES balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 1113435000.00
NTES balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 2173117000.00
NTES balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 1113435000.00
NTES balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 2173117000.00
NTES balance_sheet (annual, 2024-12-31) — Non Current Note Receivables: 17053000.00
NTES balance_sheet (quarterly, 2024-12-31) — Non Current Note Receivables: 17053000.00
NTES balance_sheet (annual, 2024-12-31) — Non Current Prepaid Assets: 143005000.00
NTES balance_sheet (quarterly, 2024-12-31) — Non Current Prepaid Assets: 143005000.00
NTES income_statement (annual, 2024-12-31) — Normalized EBITDA: 31391168000.00
NTES income_statement (annual, 2024-12-31) — Normalized Income: 29180274267.89
NTES cash_flow (annual, 2024-12-31) — Operating Cash Flow: 39676813000.00
NTES cash_flow (annual, 2024-12-31) — Operating Gains Losses: -840767000.00
NTES income_statement (annual, 2024-12-31) — Operating Income: 29583990000.00
NTES income_statement (annual, 2024-12-31) — Operating Revenue: 105295236000.00
NTES balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 3167959016.00
NTES balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 3167959016.00
NTES balance_sheet (annual, 2024-12-31) — Other Current Assets: 144068000.00
NTES balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 2961679000.00
NTES balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: 2961679000.00
NTES income_statement (annual, 2024-12-31) — Other Gand A: 4550625000.00
NTES income_statement (annual, 2024-12-31) — Other Income Expense: 1212850000.00
NTES balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 5585396000.00
NTES balance_sheet (annual, 2024-12-31) — Other Investments: 319894000.00
NTES balance_sheet (quarterly, 2024-12-31) — Other Investments: 319894000.00
NTES balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 416672000.00
NTES balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 816041000.00
NTES income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 602134000.00
NTES balance_sheet (annual, 2024-12-31) — Other Payable: 5695447000.00
NTES balance_sheet (annual, 2024-12-31) — Other Receivables: 529051000.00
NTES balance_sheet (quarterly, 2024-12-31) — Other Receivables: 529051000.00
NTES balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 86197498000.00
NTES balance_sheet (annual, 2024-12-31) — Payables: 9175181000.00
NTES balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 18046995000.00
NTES balance_sheet (annual, 2024-12-31) — Prepaid Assets: 3795633000.00
NTES balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 3795633000.00
NTES income_statement (annual, 2024-12-31) — Pretax Income: 35717755000.00
NTES balance_sheet (annual, 2024-12-31) — Properties: 0.00
NTES balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
NTES cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 68934000.00
NTES cash_flow (annual, 2024-12-31) — Purchase Of Business: -513397000.00
NTES cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -930988000.00
NTES cash_flow (annual, 2024-12-31) — Purchase Of Investment: -163616934000.00
NTES cash_flow (annual, 2024-12-31) — Purchase Of PPE: -1275400000.00
NTES balance_sheet (annual, 2024-12-31) — Receivables: 8146194000.00
NTES income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 39488152000.00
NTES income_statement (annual, 2024-12-31) — Reconciled Depreciation: 2417894000.00
NTES cash_flow (annual, 2024-12-31) — Repayment Of Debt: -14739347000.00
NTES cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -8830115000.00
NTES cash_flow (quarterly, 2024-12-31) — Repurchase Of Capital Stock: -1595093000.00
NTES income_statement (annual, 2024-12-31) — Research And Development: 17524812000.00
NTES balance_sheet (annual, 2024-12-31) — Restricted Cash: 3086405000.00
NTES balance_sheet (annual, 2024-12-31) — Retained Earnings: 130333397000.00
NTES balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 130333397000.00
NTES cash_flow (annual, 2024-12-31) — Sale Of Business: 2822585000.00
NTES cash_flow (annual, 2024-12-31) — Sale Of Investment: 182230891000.00
NTES cash_flow (annual, 2024-12-31) — Sale Of PPE: 14533000.00
NTES income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 14147657000.00
NTES income_statement (annual, 2024-12-31) — Selling General And Administration: 18698282000.00
NTES balance_sheet (annual, 2024-12-31) — Share Issued: 3211276016.00
NTES balance_sheet (quarterly, 2024-12-31) — Share Issued: 3211276016.00
NTES cash_flow (annual, 2024-12-31) — Stock Based Compensation: 3882939000.00
NTES balance_sheet (annual, 2024-12-31) — Stockholders Equity: 138685606000.00
NTES balance_sheet (annual, 2024-12-31) — Tangible Book Value: 131244917000.00
NTES income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 93381267.89
NTES income_statement (annual, 2024-12-31) — Tax Provision: 5461408000.00
NTES income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.15
NTES balance_sheet (annual, 2024-12-31) — Total Assets: 195991550000.00
NTES balance_sheet (annual, 2024-12-31) — Total Capitalization: 139113603000.00
NTES balance_sheet (annual, 2024-12-31) — Total Debt: 12817257000.00
NTES balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 142494138000.00
NTES income_statement (annual, 2024-12-31) — Total Expenses: 75711246000.00
NTES balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 53497412000.00
NTES balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 42666894000.00
NTES balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 3829755000.00
NTES income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 29583990000.00
NTES balance_sheet (annual, 2024-12-31) — Total Tax Payable: 2759185000.00
NTES income_statement (annual, 2024-12-31) — Total Unusual Items: 610716000.00
NTES income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 610716000.00
NTES balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 43317000.00
NTES balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 43317000.00
NTES balance_sheet (annual, 2024-12-31) — Treasury Stock: 4473063000.00
NTES balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 4473063000.00
NTES cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: -1372508000.00
NTES balance_sheet (annual, 2024-12-31) — Working Capital: 103656999000.00
NTES income_statement (quarterly, 2025-03-31) — +Operating Expense: 8038247000.00
NTES income_statement (quarterly, 2025-03-31) — +Total Revenue: 28828545000.00
NTES balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 565140000.00
NTES balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 6742202000.00
NTES cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 89071000.00
NTES balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 3025000000.00
NTES income_statement (quarterly, 2025-03-31) — Basic Average Shares: 634779800.00
NTES income_statement (quarterly, 2025-03-31) — Basic EPS: 16.25
NTES cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 54474923000.00
NTES cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -752842000.00
NTES balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 41748614000.00
NTES balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 140114619000.00
NTES cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -5584532000.00
NTES cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -8288158000.00
NTES cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -12841002000.00
NTES cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 12106652000.00
NTES cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -148076000.00
NTES cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -290374000.00
NTES cash_flow (quarterly, 2025-03-31) — Change In Income Tax Payable: 1796123000.00
NTES cash_flow (quarterly, 2025-03-31) — Change In Inventory: 53773000.00
NTES cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 2526198000.00
NTES cash_flow (quarterly, 2025-03-31) — Change In Payable: -437064000.00
NTES cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -727438000.00
NTES cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -295178000.00
NTES cash_flow (quarterly, 2025-03-31) — Change In Receivables: -1088960000.00
NTES cash_flow (quarterly, 2025-03-31) — Change In Tax Payable: 1796123000.00
NTES cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 468395000.00
NTES cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -1088960000.00
NTES cash_flow (quarterly, 2025-03-31) — Changes In Cash: -9022508000.00
NTES cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -5584532000.00
NTES balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 143834194000.00
NTES cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -303601000.00
NTES income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 10349139000.00
NTES balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 13827806000.00
NTES balance_sheet (quarterly, 2025-03-31) — Current Assets: 157670710000.00
NTES balance_sheet (quarterly, 2025-03-31) — Current Debt: 9824016000.00
NTES balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 9824016000.00
NTES balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 17748602000.00
NTES balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 17748602000.00
NTES balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 49138183000.00
NTES cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 328272000.00
NTES cash_flow (quarterly, 2025-03-31) — Deferred Tax: 328272000.00
NTES cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 480761000.00
NTES cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 480761000.00
NTES income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 641272400.00
NTES income_statement (quarterly, 2025-03-31) — Diluted EPS: 16.05
NTES income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 10301157000.00
NTES income_statement (quarterly, 2025-03-31) — EBIT: 10441159000.00
NTES income_statement (quarterly, 2025-03-31) — EBITDA: 10921920000.00
NTES cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: -18668000.00
NTES cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -56932000.00
NTES cash_flow (quarterly, 2025-03-31) — End Cash Position: 45395483000.00
NTES cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -8288158000.00
NTES cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 11353810000.00
NTES cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 11675000.00
NTES cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 20293000.00
NTES income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 694554000.00
NTES income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 956337000.00
NTES balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 4140969000.00
NTES balance_sheet (quarterly, 2025-03-31) — Gross PPE: 8454460000.00
NTES income_statement (quarterly, 2025-03-31) — Gross Profit: 18479406000.00
NTES cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 1206555000.00
NTES income_statement (quarterly, 2025-03-31) — Interest Income: 1060886000.00
NTES income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 1060886000.00
NTES cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 97424000.00
NTES balance_sheet (quarterly, 2025-03-31) — Inventory: 517787000.00
NTES balance_sheet (quarterly, 2025-03-31) — Invested Capital: 153658210000.00
NTES cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -12841002000.00
NTES balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 3025000000.00
NTES balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 3025000000.00
NTES cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 2747550000.00
NTES balance_sheet (quarterly, 2025-03-31) — Line Of Credit: 9824016000.00
NTES cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 2747550000.00
NTES cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -2935677000.00
NTES balance_sheet (quarterly, 2025-03-31) — Minority Interest: 4035050000.00
NTES income_statement (quarterly, 2025-03-31) — Minority Interests: -245614000.00
NTES cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -303601000.00
NTES cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -28453000.00
NTES income_statement (quarterly, 2025-03-31) — Net Income: 10301157000.00
NTES income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 10301157000.00
NTES income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 10546771000.00
NTES income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 10301157000.00
NTES income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 10301157000.00
NTES cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 10546771000.00
NTES income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 10546771000.00
NTES cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -298771000.00
NTES income_statement (quarterly, 2025-03-31) — Net Interest Income: 1060886000.00
NTES cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -12088818000.00
NTES cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -2442542000.00
NTES cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -188127000.00
NTES income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 1060886000.00
NTES cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 42517000.00
NTES cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -678000.00
NTES balance_sheet (quarterly, 2025-03-31) — Net PPE: 8454460000.00
NTES cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -452735000.00
NTES cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: -2254415000.00
NTES balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 139693225000.00
NTES balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 1283673000.00
NTES balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 2671570000.00
NTES balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 1283673000.00
NTES balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 2671570000.00
NTES income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 10227366000.00
NTES income_statement (quarterly, 2025-03-31) — Normalized Income: 9712869762.00
NTES cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 12106652000.00
NTES cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -15153000.00
NTES income_statement (quarterly, 2025-03-31) — Operating Income: 10441159000.00
NTES income_statement (quarterly, 2025-03-31) — Operating Revenue: 28828545000.00
NTES balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 3165991421.00
NTES balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 6654459000.00
NTES income_statement (quarterly, 2025-03-31) — Other Gand A: 956337000.00
NTES income_statement (quarterly, 2025-03-31) — Other Income Expense: 949869000.00
NTES balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 4140969000.00
NTES balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 26283320000.00
NTES balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 1179135000.00
NTES income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 255315000.00
NTES balance_sheet (quarterly, 2025-03-31) — Other Payable: 2614923000.00
NTES balance_sheet (quarterly, 2025-03-31) — Other Properties: 8454460000.00
NTES balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 98366005000.00
NTES balance_sheet (quarterly, 2025-03-31) — Payables: 7737759000.00
NTES balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 21565565000.00
NTES income_statement (quarterly, 2025-03-31) — Pretax Income: 12451914000.00
NTES cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 16771000.00
NTES cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: -298771000.00
NTES cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -58801329000.00
NTES cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -454071000.00
NTES balance_sheet (quarterly, 2025-03-31) — Receivables: 6742202000.00
NTES income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 10349139000.00
NTES income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 480761000.00
NTES cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -2935677000.00
NTES cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -303601000.00
NTES income_statement (quarterly, 2025-03-31) — Research And Development: 4386313000.00
NTES balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 3641643000.00
NTES cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 46712511000.00
NTES cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 1336000.00
NTES income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 2695597000.00
NTES income_statement (quarterly, 2025-03-31) — Selling General And Administration: 3651934000.00
NTES balance_sheet (quarterly, 2025-03-31) — Share Issued: 3165991421.00
NTES cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 951872000.00
NTES balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 143834194000.00
NTES balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 139693225000.00
NTES income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 106266762.00
NTES income_statement (quarterly, 2025-03-31) — Tax Provision: 1905143000.00
NTES income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.15
NTES balance_sheet (quarterly, 2025-03-31) — Total Assets: 200858132000.00
NTES balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 143834194000.00
NTES balance_sheet (quarterly, 2025-03-31) — Total Debt: 9824016000.00
NTES balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 147869244000.00
NTES income_statement (quarterly, 2025-03-31) — Total Expenses: 18387386000.00
NTES balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 52988888000.00
NTES balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 43187422000.00
NTES balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 3850705000.00
NTES income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 10441159000.00
NTES balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 4557696000.00
NTES income_statement (quarterly, 2025-03-31) — Total Unusual Items: 694554000.00
NTES income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 694554000.00
NTES cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: -760108000.00
NTES balance_sheet (quarterly, 2025-03-31) — Working Capital: 108532527000.00
NTES income_statement (quarterly, 2025-06-30) — +Operating Expense: 8991398000.00
NTES income_statement (quarterly, 2025-06-30) — +Total Revenue: 27891664000.00
NTES balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 695414000.00
NTES balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 5776412000.00
NTES cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 161463000.00
NTES balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 2935000000.00
NTES income_statement (quarterly, 2025-06-30) — Basic Average Shares: 637726800.00
NTES income_statement (quarterly, 2025-06-30) — Basic EPS: 13.50
NTES cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 45395483000.00
NTES cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -503191000.00
NTES balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 54430728000.00
NTES balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 146688862000.00
NTES cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -3082122000.00
NTES cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -1951445000.00
NTES cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 3892942000.00
NTES cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 10861863000.00
NTES cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 119644000.00
NTES cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 530718000.00
NTES cash_flow (quarterly, 2025-06-30) — Change In Income Tax Payable: -764372000.00
NTES cash_flow (quarterly, 2025-06-30) — Change In Inventory: -73944000.00
NTES cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -718719000.00
NTES cash_flow (quarterly, 2025-06-30) — Change In Payable: 275934000.00
NTES cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 806652000.00
NTES cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 583484000.00
NTES cash_flow (quarterly, 2025-06-30) — Change In Receivables: 953295000.00
NTES cash_flow (quarterly, 2025-06-30) — Change In Tax Payable: -764372000.00
NTES cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 1550768000.00
NTES cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 953295000.00
NTES cash_flow (quarterly, 2025-06-30) — Changes In Cash: 12803360000.00
NTES cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -3082122000.00
NTES balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 149587316000.00
NTES cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -355563000.00
NTES income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 9839182000.00
NTES balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 14157432000.00
NTES balance_sheet (quarterly, 2025-06-30) — Current Assets: 162950112000.00
NTES balance_sheet (quarterly, 2025-06-30) — Current Debt: 11276303000.00
NTES balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 11276303000.00
NTES balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 16966562000.00
NTES balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 16966562000.00
NTES balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 50451907000.00
NTES cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -853764000.00
NTES cash_flow (quarterly, 2025-06-30) — Deferred Tax: -853764000.00
NTES cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 428427000.00
NTES cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 428427000.00
NTES income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 642936200.00
NTES income_statement (quarterly, 2025-06-30) — Diluted EPS: 13.35
NTES income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 8601010000.00
NTES income_statement (quarterly, 2025-06-30) — EBIT: 9061084000.00
NTES income_statement (quarterly, 2025-06-30) — EBITDA: 9489511000.00
NTES cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: 13479000.00
NTES cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -31749000.00
NTES cash_flow (quarterly, 2025-06-30) — End Cash Position: 58167094000.00
NTES cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -1951445000.00
NTES cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 10358672000.00
NTES cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -141078000.00
NTES cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: -30920000.00
NTES income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 442481000.00
NTES income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 1056578000.00
NTES balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 4111093000.00
NTES balance_sheet (quarterly, 2025-06-30) — Gross PPE: 8447022000.00
NTES income_statement (quarterly, 2025-06-30) — Gross Profit: 18052482000.00
NTES cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 2184556000.00
NTES income_statement (quarterly, 2025-06-30) — Interest Income: 953490000.00
NTES income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 953490000.00
NTES cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 64366000.00
NTES balance_sheet (quarterly, 2025-06-30) — Inventory: 591756000.00
NTES balance_sheet (quarterly, 2025-06-30) — Invested Capital: 160863619000.00
NTES cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 3892942000.00
NTES balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 2935000000.00
NTES balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 2935000000.00
NTES cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 1231000000.00
NTES balance_sheet (quarterly, 2025-06-30) — Line Of Credit: 11276303000.00
NTES cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 1231000000.00
NTES cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -1804730000.00
NTES balance_sheet (quarterly, 2025-06-30) — Minority Interest: 4516836000.00
NTES income_statement (quarterly, 2025-06-30) — Minority Interests: -487455000.00
NTES cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -355563000.00
NTES cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -165662000.00
NTES income_statement (quarterly, 2025-06-30) — Net Income: 8601010000.00
NTES income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 8601010000.00
NTES income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 9088465000.00
NTES income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 8601010000.00
NTES income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 8601010000.00
NTES cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 9088465000.00
NTES income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 9088465000.00
NTES cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -313349000.00
NTES income_statement (quarterly, 2025-06-30) — Net Interest Income: 953490000.00
NTES cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 4402001000.00
NTES cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 1443840000.00
NTES cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -573730000.00
NTES income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 953490000.00
NTES cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 42400000.00
NTES cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -27367000.00
NTES balance_sheet (quarterly, 2025-06-30) — Net PPE: 8447022000.00
NTES cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -168343000.00
NTES cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: 2017570000.00
NTES balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 145476223000.00
NTES balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 2190156000.00
NTES balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 2724485000.00
NTES balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 2190156000.00
NTES balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 2724485000.00
NTES income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 9047030000.00
NTES income_statement (quarterly, 2025-06-30) — Normalized Income: 8223379307.20
NTES cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 10861863000.00
NTES cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -324181000.00
NTES income_statement (quarterly, 2025-06-30) — Operating Income: 9061084000.00
NTES income_statement (quarterly, 2025-06-30) — Operating Revenue: 27891664000.00
NTES balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 6161982000.00
NTES income_statement (quarterly, 2025-06-30) — Other Gand A: 1056578000.00
NTES income_statement (quarterly, 2025-06-30) — Other Income Expense: 634648000.00
NTES balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 4111093000.00
NTES balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 27865270000.00
NTES balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 1218109000.00
NTES income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 192167000.00
NTES balance_sheet (quarterly, 2025-06-30) — Other Payable: 3560061000.00
NTES balance_sheet (quarterly, 2025-06-30) — Other Properties: 8447022000.00
NTES balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 92258134000.00
NTES balance_sheet (quarterly, 2025-06-30) — Payables: 8051610000.00
NTES balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 22209042000.00
NTES income_statement (quarterly, 2025-06-30) — Pretax Income: 10649222000.00
NTES cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 153179000.00
NTES cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -313349000.00
NTES cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -36522246000.00
NTES cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -189842000.00
NTES balance_sheet (quarterly, 2025-06-30) — Receivables: 5776412000.00
NTES income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 9839182000.00
NTES income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 428427000.00
NTES cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -1804730000.00
NTES cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -355563000.00
NTES income_statement (quarterly, 2025-06-30) — Research And Development: 4356646000.00
NTES balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 3731100000.00
NTES cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 40924247000.00
NTES cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 21499000.00
NTES income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 3578174000.00
NTES income_statement (quarterly, 2025-06-30) — Selling General And Administration: 4634752000.00
NTES cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 946395000.00
NTES balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 149587316000.00
NTES balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 145476223000.00
NTES income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 64850307.20
NTES income_statement (quarterly, 2025-06-30) — Tax Provision: 1560757000.00
NTES income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.15
NTES balance_sheet (quarterly, 2025-06-30) — Total Assets: 208498653000.00
NTES balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 149587316000.00
NTES balance_sheet (quarterly, 2025-06-30) — Total Debt: 11276303000.00
NTES balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 154104152000.00
NTES income_statement (quarterly, 2025-06-30) — Total Expenses: 18830580000.00
NTES balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 54394501000.00
NTES balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 45548541000.00
NTES balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 3942594000.00
NTES income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 9061084000.00
NTES balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 3796135000.00
NTES income_statement (quarterly, 2025-06-30) — Total Unusual Items: 442481000.00
NTES income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 442481000.00
NTES cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: -288889000.00
NTES balance_sheet (quarterly, 2025-06-30) — Working Capital: 112498205000.00
NTES income_statement (quarterly, 2025-09-30) — +Operating Expense: 10164139000.00
NTES income_statement (quarterly, 2025-09-30) — +Total Revenue: 28358625000.00
NTES balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 718393000.00
NTES balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 5962060000.00
NTES cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 1616146000.00
NTES balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 2845000000.00
NTES income_statement (quarterly, 2025-09-30) — Basic Average Shares: 638246200.00
NTES income_statement (quarterly, 2025-09-30) — Basic EPS: 13.50
NTES cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 58167094000.00
NTES cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -474628000.00
NTES balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 31326752000.00
NTES balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 149093032000.00
NTES cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -2583740000.00
NTES cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -6391610000.00
NTES cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -24620613000.00
NTES cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 12947954000.00
NTES cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 16042000.00
NTES cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 880072000.00
NTES cash_flow (quarterly, 2025-09-30) — Change In Income Tax Payable: 517353000.00
NTES cash_flow (quarterly, 2025-09-30) — Change In Inventory: -45582000.00
NTES cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 2013062000.00
NTES cash_flow (quarterly, 2025-09-30) — Change In Payable: 533395000.00
NTES cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 1413467000.00
NTES cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -889519000.00
NTES cash_flow (quarterly, 2025-09-30) — Change In Receivables: -194823000.00
NTES cash_flow (quarterly, 2025-09-30) — Change In Tax Payable: 517353000.00
NTES cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 2296605000.00
NTES cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -194823000.00
NTES cash_flow (quarterly, 2025-09-30) — Changes In Cash: -18064269000.00
NTES cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -2583740000.00
NTES balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 156256172000.00
NTES cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 35227000.00
NTES income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 10181020000.00
NTES balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 15229406000.00
NTES balance_sheet (quarterly, 2025-09-30) — Current Assets: 171209797000.00
NTES balance_sheet (quarterly, 2025-09-30) — Current Debt: 7349967000.00
NTES balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 7349967000.00
NTES balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 19473595000.00
NTES balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 19473595000.00
NTES balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 50088565000.00
NTES cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -933553000.00
NTES cash_flow (quarterly, 2025-09-30) — Deferred Tax: -933553000.00
NTES cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 617872000.00
NTES cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 617872000.00
NTES income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 644699400.00
NTES income_statement (quarterly, 2025-09-30) — Diluted EPS: 13.35
NTES income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 8615677000.00
NTES income_statement (quarterly, 2025-09-30) — EBIT: 8013466000.00
NTES income_statement (quarterly, 2025-09-30) — EBITDA: 8631338000.00
NTES cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: 1389265000.00
NTES cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -117878000.00
NTES cash_flow (quarterly, 2025-09-30) — End Cash Position: 39984947000.00
NTES cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -6391610000.00
NTES cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 12473326000.00
NTES cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -38072000.00
NTES cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 404000.00
NTES income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 1005590000.00
NTES income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 1164573000.00
NTES balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 4078719000.00
NTES balance_sheet (quarterly, 2025-09-30) — Gross PPE: 8517182000.00
NTES income_statement (quarterly, 2025-09-30) — Gross Profit: 18177605000.00
NTES cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 1967228000.00
NTES income_statement (quarterly, 2025-09-30) — Interest Income: 936706000.00
NTES income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 936706000.00
NTES cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 207879000.00
NTES balance_sheet (quarterly, 2025-09-30) — Inventory: 637325000.00
NTES balance_sheet (quarterly, 2025-09-30) — Invested Capital: 163606139000.00
NTES cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -24620613000.00
NTES balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 2845000000.00
NTES balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 2845000000.00
NTES cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 35227000.00
NTES cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 1481550000.00
NTES balance_sheet (quarterly, 2025-09-30) — Line Of Credit: 7349967000.00
NTES cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 1481550000.00
NTES cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -5879605000.00
NTES balance_sheet (quarterly, 2025-09-30) — Minority Interest: 4675810000.00
NTES income_statement (quarterly, 2025-09-30) — Minority Interests: -176927000.00
NTES cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 35227000.00
NTES cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: 368559000.00
NTES income_statement (quarterly, 2025-09-30) — Net Income: 8615677000.00
NTES income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 8615677000.00
NTES income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 8792604000.00
NTES income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 8615677000.00
NTES income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 8615677000.00
NTES cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 8792604000.00
NTES income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 8792604000.00
NTES cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: -190983000.00
NTES income_statement (quarterly, 2025-09-30) — Net Interest Income: 936706000.00
NTES cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -24222588000.00
NTES cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -3861169000.00
NTES cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -4398055000.00
NTES income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 936706000.00